354 related articles for article (PubMed ID: 17551992)
1. Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Volkers AC; Heerdink ER; van Dijk L
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1054-62. PubMed ID: 17551992
[TBL] [Abstract][Full Text] [Related]
2. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
Rushton JL; Clark SJ; Freed GL
Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
[TBL] [Abstract][Full Text] [Related]
3. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
[TBL] [Abstract][Full Text] [Related]
4. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.
Lawrenson RA; Tyrer F; Newson RB; Farmer RD
J Affect Disord; 2000 Aug; 59(2):149-57. PubMed ID: 10837883
[TBL] [Abstract][Full Text] [Related]
5. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database.
Murray ML; de Vries CS; Wong IC
Arch Dis Child; 2004 Dec; 89(12):1098-102. PubMed ID: 15557040
[TBL] [Abstract][Full Text] [Related]
6. Physicians' prescribing preferences were a potential instrument for patients' actual prescriptions of antidepressants.
Davies NM; Gunnell D; Thomas KH; Metcalfe C; Windmeijer F; Martin RM
J Clin Epidemiol; 2013 Dec; 66(12):1386-96. PubMed ID: 24075596
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
Murray ML; Thompson M; Santosh PJ; Wong IC
Drug Saf; 2005; 28(12):1151-7. PubMed ID: 16329717
[TBL] [Abstract][Full Text] [Related]
8. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
[TBL] [Abstract][Full Text] [Related]
9. [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].
Bramness JG; Engeland A; Furu K
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2653-5. PubMed ID: 17952146
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
11. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
Einarson TR; Arikian SR; Casciano J; Doyle JJ
Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
13. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study.
Bauer M; Monz BU; Montejo AL; Quail D; Dantchev N; Demyttenaere K; Garcia-Cebrian A; Grassi L; Perahia DG; Reed C; Tylee A
Eur Psychiatry; 2008 Jan; 23(1):66-73. PubMed ID: 18164600
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
15. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
[TBL] [Abstract][Full Text] [Related]
16. One-year costs of second-line therapies for depression.
Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
[TBL] [Abstract][Full Text] [Related]
17. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):170-179. PubMed ID: 27868277
[TBL] [Abstract][Full Text] [Related]
18. The pharmacoeconomics of venlafaxine in depression.
Morrow TJ
Am J Manag Care; 2001 Sep; 7(11 Suppl):S386-92. PubMed ID: 11570029
[TBL] [Abstract][Full Text] [Related]
19. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
